Jin Medical International Limited Receives Nasdaq Notification Letter Regarding Noncompliance With Continued Listing Rule 5550(a)(3)
Portfolio Pulse from Benzinga Newsdesk
Jin Medical International Limited has received a Nasdaq notification letter regarding noncompliance with continued listing rule 5550(a)(3).
September 28, 2023 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jin Medical International Limited, listed as ZJYL, is noncompliant with Nasdaq listing rule 5550(a)(3). This could potentially lead to delisting if not rectified.
Noncompliance with Nasdaq listing rules can lead to delisting, which would negatively impact the stock's liquidity and potentially its price. The company will need to rectify this noncompliance to avoid such consequences.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100